Eslicarbazepine
RxNorm 1482502
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1482502 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: eslicarbazepine.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Eslicarbazepine
(Atom ID: 5911588)
PTPrescribable
Designated preferred name (PT):
Eslicarbazepine
(Atom ID: 5939529)
FNPrescribable
Full form of descriptor (FN):
Eslicarbazepine (substance)
(Atom ID: 5939530)
PTPrescribable
Designated preferred name (PT):
Eslicarbazepine-containing product
(Atom ID: 10802421)
FNPrescribable
Full form of descriptor (FN):
Product containing eslicarbazepine (medicinal product)
(Atom ID: 10306382)
Patient Education
Eslicarbazepine
Eslicarbazepine is used in combination with other medications to control focal (partial) seizures (seizures that involve only one part of the brain). Eslicarbazepine is in a class of medications called anticonvulsants. It works by decreasing abnormal excitement in the brain.
[Learn More]
* Please review the disclaimer below.